TEVETENĀ® HCT (eprosartan mesylate/hydrochlorothiazide) is a combined ARB and diuretic (hydrochlorothiazide) indicated for the treatment of hypertension. Usual recommended starting dose: 600mg/12.5mg once daily when used as combination therapy in patients who are not volume-depleted. Recommended dose range: 600mg/12.5mg to 600mg/25mg. Active Ingredients: eprosartan mesylate, hydrochlorothiazide.
Product Category:
Blood Pressure ManagementSub-category:
Blood Pressure MedicationsProduct Features:
- Contact manufacturer for further details
Other Features:
How Supplied/Sizing:
Tablet: 600mg eprosartan/12.5mg HCTZ; 600mg eprosartan/25mg HCTZ.
Company information:
- Street:
- Pharmaceutical Products Division
- Additional:
- 100 Abbott Park Rd.
- City:
- Abbott Park ,
- Province:
- Illinois
- Postal Code:
- 60064-3500
- Country:
- United States
Broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health.
Website:
www.abbott.com
Phone:
847-937-6100